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Abstract
Circular RNAs (circRNAs) represent a class of covalently closed RNAs, derived from non-canonical splicing events, which
are expressed in all eukaryotes and often conserved among different species. We previously showed that the circRNA
originating from the ZNF609 locus (circ-ZNF609) acts as a crucial regulator of human primary myoblast growth: indeed, the
downregulation of the circRNA, and not of its linear counterpart, strongly reduced the proliferation rate of in vitro cultured
myoblasts. To deepen our knowledge about circ-ZNF609 role in cell cycle regulation, we studied its expression and function
in rhabdomyosarcoma (RMS), a pediatric skeletal muscle malignancy. We found that circ-ZNF609 is upregulated in biopsies
from the two major RMS subtypes, embryonal (ERMS) and alveolar (ARMS). Moreover, we discovered that in an ERMS-
derived cell line circ-ZNF609 knock-down induced a specific block at the G1-S transition, a strong decrease of p-Akt protein
level and an alteration of the pRb/Rb ratio. Regarding p-Akt, we were able to show that circ-ZNF609 acts by counteracting
p-Akt proteasome-dependent degradation, thus working as a new regulator of cell proliferation-related pathways. As
opposed to ERMS-derived cells, the circRNA depletion had no cell cycle effects in ARMS-derived cells. Since in these cells
the p53 gene resulted downregulated, with a concomitant upregulation of its cell cycle-related target genes, we suggest that
this could account for the lack of circ-ZNF609 effect in ARMS.
Introduction
CircRNAs are eukaryotic transcripts produced through a
peculiar splicing reaction (back-splicing), which causes the
circularization of one or more exons. The resulting mole-
cules are characterized by a back-splicing junction and lack
5ʹ and 3ʹ free termini [1, 2]. Having such a shape, circRNAs
are typically very stable molecules [3], a trait which has
captivated a broad interest concerning their possible mole-
cular activity. To date, despite the large number of identified
circRNAs, the study of their mechanism of action remains
largely unexplored. Moreover, quite diverse functions
have been described so far for the few species studied:
some molecules were shown to bind microRNAs,
possibly acting as decoys or modulating their activity and
localization [2, 4–7], while others were reported as RNA
binding protein scaffolds or decoys [8, 9] or even to have
protein coding ability [10–12].
So far, many circRNAs have been shown to be involved
in cell cycle progression and several studies have focused
on their role in abnormal proliferation of cancer cells.
Overall, it seems that circRNAs could be a promising class
of molecules for the better understanding of cancer pro-
gression, and thus have been studied in different cancer
types [13–16]. Moreover, Guarnerio et al. [17]. showed that
fusion-circRNAs, derived from tumor-associated chromo-
somal translocations, sustain cell proliferation and tumor
aggressiveness.
We recently reported a knock-down based screening of
circRNAs expressed in human myogenesis [10]. The
knock-down of 25 targets followed by a detailed phenotypic
characterization yielded one interesting molecule, circ-
ZNF609, expressed in growing myoblasts and whose
depletion resulted in the alteration of cell proliferation.
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In this paper, we focus on the biological function of
circ-ZNF609, describing its impact on myoblasts gene
expression. Furthermore, because of circ-ZNF609 ability to
promote myoblast proliferation, we studied its expression,
function, and effects on the transcriptome in rhabdomyo-
sarcoma (RMS), a pediatric skeletal muscle malignancy.
RMS accounts for roughly 5% of all pediatric tumors and
it is the most common soft tissue sarcoma occurring in
childhood [18]. It is a heterogeneous tumor, originating
from mesenchymal precursor cells which express skeletal
muscle markers but fail to complete a proper differentiation
program [19, 20]. In children, RMS is conventionally
classified in two main histological subtypes, the embryonal
rhabdomyosarcoma (ERMS), more frequent and pre-
cocious, and the alveolar rhabdomyosarcoma (ARMS),
which is associated to specific genetic alterations and has a
generally worse prognosis due to its scarce response to
treatment [18, 19]. Here we report that circ-ZNF609 is up
regulated in RMS biopsies and cell lines. Furthermore, its
depletion globally affects genes related to cell cycle and cell
division in the ERMS subtype, blocking cell proliferation at
the G1-S cell cycle checkpoint.
Results
Circ-ZNF609 depletion affects cell cycle genes and
triggers immune response genes
To study circ-ZNF609 impact on gene expression,
we treated human primary myoblasts with a control siRNA
(si-SCR) or with an siRNA targeting the back-splicing
junction (Fig. 1a, si-Circ) [10], in such way that the cir-
cRNA can be specifically silenced without affecting its
linear counterpart (Figure S1A). FACS analysis indicated
that, in comparison to a control siRNA (si-SCR), the spe-
cific knock-down of circ-ZNF609 induced a consistent
arrest of proliferation (Fig. 1b). Then, transcriptomes of
human primary myoblasts from two independent knock-
down experiments were studied by means of ribosomal
depleted total RNA sequencing (RNA-Seq). Gene
expression-based clustering of samples showed that control
siRNA-treated cells and specific siRNA-treated cells have
clearly distinct expression profiles (Figure S1B). Differ-
ential expression analysis revealed 204 and 116 genes,
respectively down regulated and up regulated in circ-
ZNF609-depleted cells (adjusted p-value < 0.05, absolute
log2 fold change > 0.5). These genes are listed in Table S1.
We then performed a functional enrichment analysis of
downregulated and upregulated genes. The Biological
Process GO terms enriched among the downregulated
genes were mostly associated with cell cycle and mitosis,
in agreement with the cell cycle arrest observed upon
circ-ZNF609 depletion (Fig. 1c). On the other hand, an
interesting association between the upregulated genes and
GO terms related to the innate immune response and the
interferon (IFN) signaling pathway (Fig. 1c) was also
detected. However, IFN genes were not altered in their
expression (Table S2), thus suggesting that the activation of
the downstream genes can be independent from the IFN
signaling and may be directly involved in cell cycle reg-
ulation, as already reported [21–24].
We used qRT-PCR to validate a set of differentially
expressed genes in three biological replicates of the knock-
down experiment (Fig. 1d). In particular, we analyzed
E2F1, CDK1, cyclin A2 (CycA2), cyclin B1 (CycB1), and
cyclin B2 (CycB2), which are related to the cell cycle.
These data were consistent with the RNA-Seq results.
To exclude possible off-target effects due to non-specific
knock-down of the ZNF609 mRNA, as well as other
unrelated targets, we validated the modulation of the
selected genes using two additional siRNAs: one targeting
the linear mRNA (si-Lin) and the other targeting both iso-
forms (si-Circ+Lin) (Fig. 1a). As shown in Fig. 1e, f, si-Lin
did not affect the genes modulated by si-Circ, while si-Circ
+Lin did, hence indicating that E2F1, CDK1, CycA2,
CycB1, and CycB2 expression is specifically responsive to
circ-ZNF609 knock-down.
Circ-ZNF609 is upregulated in RMS
Since circ-ZNF609 is involved in myoblast proliferation,
we focused our attention on RMS, a solid malignant tumor
of the skeletal muscle. We initially measured circ-ZNF609
expression in wild-type (WT) myoblasts versus RMS cell
lines (RD and RH4 cells, two in vitro models of ERMS and
ARMS subtypes, respectively) and found a consistent
upregulation of the circRNA in both the tumor cell lines,
with particularly higher levels in the alveolar type (Fig. 2a).
These observations may suggest that circ-ZNF609 plays a
role in sustaining the aberrant proliferation rate of RMS
cells.
We then looked at circ-ZNF609 expression in primary
tumor biopsies obtained from 11 patients with RMS
(6 ERMSs and 5 ARMSs), compared with skeletal muscle
biopsies from three age-matched healthy donors. We found
that circ-ZNF609 RNA levels are 5 to ∼50-fold higher in
RMS tumors (Fig. 2b).
When looking at the ZNF609 linear mRNA counterpart,
we found a similar pattern: up regulation in both RMS cell
lines (Fig. 2c), and in RMS tumors (Fig. 2d). These findings
suggest that the mechanism underlying such altered
expression is likely related to the transcriptional activation
of the gene.
We also checked circ-ZNF609 subcellular localization
by fluorescent in situ hybridization (FISH), using a probe
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targeting the back-splicing junction of the circRNA. We
performed this experiment in RD and RH4 RMS cell lines,
and we observed that in both types of cells circ-ZNF609
localizes in specific cytoplasmic spots (Figs. 2e, S1C, D).
The specificity of this signal was proven by its dis-
appearance when cells were treated with si-Circ (Fig. S1E).
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As control, the use of a probe specific for the linear coun-
terpart indicated a higher number of cytoplasmic spots (Fig.
S1F, left). Finally, a bacterial-specific probe provided no
signal (Fig. S1F, right). These results suggest that the circ-
ZNF609 molecules are localized in a specific cytoplasmic
sub-compartment. The FISH method utilized (see supple-
mentary material) has a single-molecule detection sensitiv-
ity, however we believe that many of the identified spots
could contain multiple copies of circ-ZNF609. This
is mainly suggested by the different diameter of the spots
(Fig. S1C, asterisks); unfortunately, due to the signal
amplification procedure as well as to the optical microscope
resolution limitations, at the moment it is impossible to
exactly establish the number of copies inside each spot.
Circ-ZNF609 depletion causes ERMS (but not ARMS)
proliferation arrest in vitro
To study the biological role of circ-ZNF609 in RMS, we
treated RD and RH4 cell lines with either si-SCR or si-Circ,
and analyzed the effects on cell cycle progression. si-Circ
induced a strong and reproducible block of the G1/S tran-
sition in RD cells (Figs. 3a and S2A), whilst no effect on the
cell cycle was observed upon depletion of circ-ZNF609 in
RH4 cells (Figs. 3b and S2B). The use of si-Circ+Lin and
si-Lin proved that the effects observed in RD cells were
specifically due to the circular form (Fig. S2C). Moreover,
the genes modulated after circ-ZNF609 depletion in myo-
blasts (E2F1, CDK1, CycA2, CycB1, and CycB2) were
found to be similarly affected in RD (Fig. 3c), but not in
RH4 cells (Fig. 3d), with the exception of E2F1, whose
levels were consistently upregulated (Fig. 3d). These find-
ings demonstrate a relevant difference between the two
RMS subtypes that could account for the more aggressive
phenotype of ARMS cells and for their insensitivity to circ-
ZNF609 knock-down.
Since in RD cells we observed the G1-S proliferation
block and the down regulation of E2F1-targets, such as
CDK1, CycA2, CycB1, CycB2 (Fig. 3c), PCNA and some
DNA polymerase subunits (see RNA-Seq data discussed
below and Table S1) [25–28], we decided to investigate
some well-known protein factors regulating G1-S transition
and cell proliferation. In particular, we focused our attention
on the Retinoblastoma (Rb) and Akt proteins. Interestingly,
in both RD and RH4 cells, and despite their different phe-
notypic response to circ-ZNF609 knock-down, these cell
cycle-related proteins were found to respond to circ-
ZNF609 depletion in a similar manner.
The Rb protein is a known regulator of the G1-S cell cycle
checkpoint by controlling E2F1, a transcription factor that
induces the expression of the S-phase genes. In particular,
hypo-phosphorylated Rb can bind E2F1, therefore blocking
its ability to activate S-phase genes and so causing G1-S
arrest. In RD cells, a reduction of the total amount of Rb
protein was observed, despite no changes in its mRNA level
(Figs. 3e and S2D); moreover, protein decrease was accom-
panied by a strong decrease of its phosphorylated form,
leading to a ratio between p-Rb and Rb down to approxi-
mately 50% compared to control conditions (Figs. 3e and
S2D). These findings agree with data indicating that E2F1
targets are downregulated upon circ-ZNF609 depletion
(Fig. 3c and Table S1). Therefore, the reduced p-Rb/Rb ratio,
together with a slightly reduced E2F1 expression (Fig. 3c)
upon circ-ZNF609 depletion, can likely induce the G1-S
block. Also in RH4 cells, the levels of total Rb and of p-RB
decreased after the circRNA depletion, despite an unaltered
mRNA level (Figs. 3f and S2E); however, in these cells the
pRb/Rb ratio decreased, but not reproducibly (Figs. 3f and
S2E). Notably, the phosphorylated Akt (p-Akt), which has a
crucial role in sustaining cell proliferation [29], was reduced
upon circ-ZNF609 depletion in both RMS cell lines, while
total Akt levels remained unaffected (Figs. 3e, f and S2D–E).
In conclusion, these experiments indicate that, even if the
depletion of circ-ZNF609 has no effect on the proliferative
features of RH4 cells, it maintains the specificity of action
by targeting specific regulators of the cell cycle.
To investigate whether the decrease in Rb and p-Akt
protein levels upon circ-ZNF609 knock-down was due to an
increased protein degradation, we treated RD cells with a
proteasome inhibitor (MG132) upon si-SCR or si-Circ
transfection. As a positive control for proteasome inhibition
we used p27Kip1 [30]. We observed that Rb protein levels
did not increase upon proteasome inhibition, whereas p-Akt
accumulated in si-Circ upon MG132 treatment (Figs. 3g and
S2F).
Circ-ZNF609 knock-down induces different
transcriptomic responses in ERMS and ARMS
Since circ-ZNF609 knock-down has different effects
depending on the RMS subtype, we decided to investigate
and compare transcriptomic changes following its depletion
in ERMS and ARMS cell lines. We performed RNA-Seq on
Fig. 1 a Schematic representation of the siRNAs used against circ-
ZNF609 and/or its linear counterpart, ZNF609 mRNA. Ex.2= Exon 2;
BS J.= back-splicing junction. b Cell cycle analysis by flow cyto-
metry (FACS) of human primary myoblasts in growth conditions
upon control treatment (si-SCR) or circ-ZNF609 knock-down
(si-Circ). N= 2. c Gene Ontology (GO) term enrichment analysis
(Biological Process) performed on genes down regulated (white) and
up regulated (gray) upon circ-ZNF609 depletion in human primary
myoblasts in growth conditions. d–f RNA levels measured by qRT-
PCR of circ-ZNF609 (Circ.), ZNF609 (Lin.) and some genes involved
in cell cycle (E2F1, CDK1, Cyclin A2, Cyclin B1, Cyclin B2) in si-
SCR and either si-Circ (d), or si-Lin (e), or si-Circ+ Lin (f), in human
primary myoblasts in growth conditions. Data are shown as means ±
standard error of technical duplicates. N= 3
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two replicates of RD cells and RH4 cells in control (si-SCR)
and circ-ZNF609 knock-down (si-Circ) conditions
(Fig. S2G). As shown in Fig. S2H, gene expression-based
clustering of samples correctly recapitulates cell identities.
After performing a differential expression analysis, we
investigated the GO terms significantly associated to genes
downregulated and upregulated in circ-ZNF609 depleted
cells (lists of differentially expressed genes are reported in
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Fig. 2 a RNA levels measured
by qRT-PCR of circ-ZNF609 in
wild-type human primary
myoblasts (WT), RD cell line
and RH4 cell line. Data are
shown as means ± standard
error of technical duplicates.
N= 3. b RNA levels measured
by qRT-PCR of circ-ZNF609 in
healthy skeletal muscle
(Healthy, N= 3), embryonal
RMS (ERMS, N= 6) and
alveolar RMS (ARMS, N= 5)
samples from pediatric age-
matched patients. Data are
shown as means ± standard error
of technical triplicates. c RNA
levels measured by qRT-PCR of
ZNF609 in wild-type human
primary myoblasts (WT), RD
cell line and RH4 cell line. Data
are shown as means ± standard
error of technical duplicates.
N= 3. d RNA levels measured
by qRT-PCR of ZNF609 in
healthy skeletal muscle
(Healthy, N= 3), embryonal
RMS (ERMS, N= 6) and
alveolar RMS (ARMS, N= 5)
samples from pediatric age-
matched patients. Data are
shown as means ± standard error
of technical triplicates. e FISH in
RD cells (left) and RH4 cells
(right) using a circ-ZNF609-
specific probe
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Table S1). As expected, in RD cells the Biological Process
GO terms enriched among the downregulated genes were
mostly associated with cell cycle progression, DNA
replication and mitosis, whereas amongst the upregulated
genes we found different categories, including “Response to
interferon-gamma” (Fig. 4a, upper panel). On the contrary,
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RH4 cells did not show any enriched category strictly
related to cell cycle regulation among downregulated genes,
and any enriched category among the upregulated ones
(Fig. 4a, lower panel).
We then performed a GGEA (Gene Graph Enrichment
Analysis) [31] to compute consistency of the observed
differential expression data with the regulatory interactions
known for different KEGG pathways [32]. Among the most
significant and consistent results for RD cells there were
numerous pathways related to cell cycle, such as “DNA
replication”, “Cell cycle” and “PI3K-Akt signaling path-
way” (Figs. S3A and Table S3). On the other hand, in RH4
cells less significant results were obtained, among which the
most interesting were represented by TGF-beta, Hippo and
PI3K-Akt signaling pathways (Figs. S3B and Table S3).
To investigate the upstream regulators of these tran-
scriptomic responses in RD and RH4 cells upon circ-
ZNF609 knock-down, we performed msVIPER (Virtual
Inference of Protein-activity by Enriched Regulon) analysis
[33] in order to determine which protein factors could be
responsible for the transcriptional alteration of the different
regulons involved in cell proliferation. In RD cells, msVI-
PER analysis indicated TCF19, CENPU, MCM5–7 and
ZWINT among the transcription factors whose activity was
repressed (Fig. 4b, left). Interestingly, these genes were
down regulated upon circ-ZNF609 depletion (Fig. S3C,
left). They are also known to generally promote G1-S
transition or chromosome segregation [34–41] and, in the
case of TCF19 and MCMs, to be predicted or validated
direct targets of E2F1 [27, 42–44].
Differently to what was observed in RD, in RH4 cells
msVIPER results had higher p-values and a less obvious
relationship to the cell cycle regulation (Fig. 4b, right).
Notably, TCF19, CENPU, MCM7 and ZWINT expression
levels were not affected upon circ-ZNF609 knock-down
(Fig. S3C, right), even if expressed at lower levels than in
RD cells (Fig. S3D, MCM7, CENPU, ZWINT: asterisks).
Moreover, the expression levels of downstream cell-cycle
related genes, many of which were even more highly
expressed in RH4 than in RD cells, were not affected (Fig.
S3D). Interestingly, a significant subset of cell cycle related
genes up regulated in RH4 (CDK2, CDKN1B, E2F7, E2F1,
ZNF385A, PCBP4, CCNA2, CCNA1, CCNE1, CCNE2) is
composed of p53 targets (FDR= 4.02e−02 for the enrich-
ment of Reactome [45] pathway “TP53 Regulates Tran-
scription of Genes Involved in G1 Cell Cycle Arrest”). The
p53 gene is mutated in both RD (gain-of-function R248W
homozygous mutation) and RH4 cells (frameshift deletion
of 1001–1013 nucleotides) [46–48]; moreover, p53
expression levels are significantly lower in RH4 than in RD
cells (Table S1). These features might explain the sig-
nificantly high expression of the p53 target genes involved
in cell cycle regulation in RH4 cells as well as the lack of an
effect of circ-ZNF609 depletion on the ARMS cell line.
Altogether, these results suggest that circ-ZNF609 can
control a specific part of the transcriptome in RD cells,
similarly to what is observed in human primary myoblasts,
by inducing, when downregulated, a specific gene expres-
sion response related to the cell cycle and therefore fully
consistent with the observed G1-S arrested phenotype. On
the other hand, in RH4 cells, circ-ZNF609 depletion indu-
ces a less clear effect on the transcriptome, with very limited
alterations of cell proliferation-related genes and on IFN
response-related genes (Fig. S3E), hence likely reflecting
the lower p53 levels.
Discussion
Circular RNAs represent a recently re-discovered class of
covalently closed RNAs, produced by all eukaryotic cell types
and conserved among different species. A general mechanism
of function has not been discovered, however their con-
servation, tissue-specificity and abundance suggest possible
biological roles. Here we focused on circ-ZNF609 and on its
role in regulating cell cycle progression in RMS. Through
sequencing of RNA from human primary myoblasts depleted
of circ-ZNF609, we discovered that this circRNA controls
two well-defined classes of genes: cell cycle-related and
innate immune response genes, that are respectively down-
regulated and upregulated. Notably, these opposing effects
seem to suggest that these two classes of genes act on a
common pathway of proliferation control. Indeed, since there
Fig. 3 a Cell cycle analysis by flow cytometry (FACS) of RD
cells upon control treatment (si-SCR) or circ-ZNF609 knock-down
(si-Circ). N= 3. b Cell cycle analysis by flow cytometry (FACS) of
RH4 cells upon control treatment (si-SCR) or circ-ZNF609 knock-
down (si-Circ). N= 3. c, d RNA levels measured by qRT-PCR of circ-
ZNF609 (Circ.), ZNF609 (Lin.) and some genes involved in cell cycle
(E2F1, CDK1, Cyclin A2, Cyclin B1, Cyclin B2) in si-SCR or si-Circ
conditions in RD cells (c) and in RH4 cells (d). Data are shown as
means ± standard error of technical duplicates. N= 3. e Western blot
in RD cells in si-SCR and si-Circ conditions (Gapdh hybridization was
used as loading control). Corresponding ratio of pRb/Rb protein levels,
Akt and p-Akt protein levels (relative to Gapdh) and RNA levels
(measured by qRT-PCR of circ-ZNF609 (Circ.), ZNF609 (Lin.) and
Rb) are shown. qRT-PCR data are shown as means ± standard error of
technical duplicates. The experiment was repeated at least three times
(N= 3). f Western blot in RH4 cells in si-SCR and si-Circ conditions
(Gapdh hybridization was used as loading control). Corresponding
ratio of pRb/Rb protein levels, Akt and p-Akt protein levels (relative to
Gapdh) and RNA levels (measured by qRT-PCR of circ-ZNF609
(Circ.), ZNF609 (Lin.) and Rb) are shown. qRT-PCR data are shown
as means ± standard error of technical duplicates. The experiment was
repeated at least three times (N= 3). g Proteasome inhibition experi-
ment in RD cells treated with either si-SCR or si-Circ: western blot and
RNA analysis by qRT-PCR of circ-ZNF609 (Circ.) and ZNF609
(Lin.). qRT-PCR data are shown as means ± standard error of technical
duplicates. The experiment was repeated at least three times (N= 3)
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is evidence that IFN stimulated genes induce cell cycle block
[21–24], it is possible that the induction of the innate immune
response genes can cooperate with the proliferative arrest
observed upon circ-ZNF609 depletion.
A
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To deepen our knowledge regarding circ-ZNF609 role in
cell proliferation control, we studied its expression and
function in RMS. Circ-ZNF609 resulted upregulated in cell
lines and primary samples from both ERMS and ARMS
tumors. RNA sequencing in the RD (ERMS) cell line upon
circ-ZNF609 knock-down highlighted a similar gene
expression response as in human primary myoblasts, with
the downregulation of several genes involved in cell cycle
control. Moreover, in RD cells the depletion of the circRNA
induced a specific block at the G1-S transition. Searching
for the factors and pathways possibly involved in such a
block, we found that p-Rb/Rb ratio and p-Akt protein level
were strongly decreased, whilst the level of the corre-
sponding mRNAs was not affected significantly. In the case
of p-Akt, we were also able to show that circ-ZNF609
counteracts p-Akt proteasome-dependent degradation, thus
working as a new regulator of cell proliferation-related
pathways. Notably, the transcriptional outcome of circ-
ZNF609 depletion resulted in the downregulation of well-
known genes directly targeted by Rb through E2F1 reg-
ulation: among them CycA2, CycB1, PCNA, some DNA
polymerase subunits, and transcriptional regulators such as
MCMs and TCF19. Of these factors, we identified TCF19,
MCM7, together with CENPU and ZWINT, as the master
regulators of G1-S transition which are deregulated upon
circ-ZNF609 depletion.
As opposed to RD, in ARMS-derived RH4 cell lines, the
depletion of the circRNA did not induce any block of cell
proliferation and transcriptional analysis did not highlight
any modulation of the aforementioned cell cycle related
genes, even if the levels of Rb, p-Rb, and p-Akt proteins
were affected in a similar manner to RD cells.
Searching for differences that could explain the variation
between the behavior of the two RMS subtypes, we found a
strong downregulation the p53 gene in RH4 cells; indeed,
the analysis of p53 cell cycle-related target genes indicated
that in these cells they are strongly up regulated when
compared to RD. This difference could explain why circ-
ZNF609 knock-down cannot induce proliferation arrest in
ARMS-derived RH4 cells. ARMS is the most aggressive
RMS subtype and many pathways involved in cell pro-
liferation are altered in this tumor, meaning that the effects
of circ-ZNF609 alone may not be sufficient for a significant
reduction in the rate of cell growth.
We are very much intrigued by the characterization of
the molecular mechanisms through which circ-ZNF609
affects pRb/Rb ratio and p-Akt protein levels, as well as the
levels of G1-S transition master regulators. In particular, the
translational control of Rb and the protection of p-Akt from
proteasomal degradation represent the two most interesting
and promising examples to highlight potential novel reg-
ulatory mechanisms mediated by circRNAs. We believe
that the identification of the RNA and protein interactors of
circ-ZNF609 (possible RNA-RNA interactions controlling
protein translation or RNA-protein complexes mediating
proteasomal activity) will be instrumental to distinguish
between direct and indirect effects and to approach the
clarification of its mechanisms of action as well as the link
with the cell cycle phenotype.
The pathways described in our work seem to differ from
what was recently described by Peng et al. [49] in Hirsch-
sprung disease biopsies. In their case, circ-ZNF609 was
proposed to inhibit cell proliferation by acting as a com-
peting endogenous RNA for miR-150-5p, modulating the
expression of its target Akt3. Indeed, we checked whether
the Akt3 protein and RNA levels were affected by the
downregulation of circ-ZNF609, but neither of them was
downregulated (Fig. S3F). It is therefore likely that in our
model system circ-ZNF609 is not acting through this
circuitry.
In conclusion, by investigating the differences between
RD and RH4 transcriptomic responses to circ-ZNF609
depletion we have contributed towards clarifying the path-
ways controlled by this molecule. Future studies in our
laboratory will be aimed at the further elucidation of
the mechanism through which the circRNA controls the Rb,
p-Rb and p-Akt levels in order to gain further knowledge
regarding the processes that correlate circ-ZNF609 levels
with cell proliferation.
Materials and methods
Cell culture and transfections
Wild-type human primary myoblasts (Telethon Biobank)
were obtained from a skeletal muscle biopsy from a 2-year-
old male child. They were cultured in growth medium
(GM): DMEM (Sigma-Aldrich, Saint Louis, MO, USA),
10% FBS (Sigma-Aldrich), L-glutammine (Sigma-Aldrich)
2 mM, insulin (Sigma-Aldrich) 50 mg/ml, FGFb (Millipore
- Merck) 25 ng/ml, EGF (Corning, Corning, NY, USA)
Fig. 4 a Gene Ontology (GO) term enrichment analysis (Biological
Process) performed on genes downregulated (white) and upregulated
(gray) upon circ-ZNF609 depletion in RD cells (upper panel) and RH4
cells (lower panel). For RH4 cells, there was not any enriched category
for upregulated genes. b msVIPER analysis plot for RD cells (left) and
RH4 cells (right) showing the transcriptional status (blue= repressed,
red= activated) of the target genes for each differentially active
transcriptional regulator (genes are represented by vertical bars in each
horizontal row), drawn using the plot.msviper function. The right side
of the figure displays the inferred differential activity (first column,
red= activated and blue= de-activated) and expression (second col-
umn, gray= not expressed and white= expressed), with the rank of
the displayed genes in the VIPER inferred gene expression signature
(numbers at the right side of the plot). p-values refer to the differential
activity of the factor calculated by msVIPER
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1 ng/ml, penicillin-streptomycin 1 × (Sigma-Aldrich).
Human ERMS RD cell line and ARMS RH4 cells line [50]
were cultured in DMEM (Sigma-Aldrich) supplemented
with 10% FBS (Sigma-Aldrich), L-glutammine (Sigma-
Aldrich) 2 mM and penicillin-streptomycin (Sigma-
Aldrich). RD and RH4 cell lines were the same as Megiorni
et al. [51] used in their work, and they were previously
authenticated as described in [51]. No information available
about human primary myoblasts (Telethon Biobank)
authentication. All cell lines were tested for mycoplasma
contamination.
To transfect cells, 3 pmol siRNA (Dharmacon, Lafayette,
CO, USA) and 0.15 μl Dharmafect transfection reagent 1
(Dharmacon) in 150 μl DMEM (Sigma-Aldrich) were added
to each 100 μl of culture medium in the plate. The mixture
was vortexed for 10 s, left at room temperature for 20 min
and then seeded in the plate. Medium was replaced 24 h
after the transfection. siRNAs used in this work (si-SCR, si-
Circ, si-Lin, si-Circ+Lin) were described in [10], where
they are named si-scr, si-circ, si-mRNA, and si-ex2
respectively.
Patient biopsies
Tumor samples from 11 primary RMS tumors, 5 ARMSs
and 6 ERMSs, were obtained at diagnosis before any treat-
ment from children admitted to the Department of Oncology
at Alder Hey Children’s NHS Foundation Trust, Liverpool,
United Kingdom. Control RNA was extracted from normal
skeletal muscle biopsies obtained from 3 children under-
going surgery for non-oncological conditions. Institutional
written informed consent was obtained from the patient’s
parents or legal guardians. The study underwent ethical
review and approval according to the local institutional
guidelines (Alder Hey Children’s NHS Foundation Trust
Ethics Committee, approval number 09/H1002/88).
Proteasome inhibition
Cells in 10 cm plates were transfected with si-SCR or si-
Circ (Dharmacon) as previously described. Twenty-four
hours after transfection, si-Circ-transfected cells were split
into three 60 mm plates and the si-SCR-transfected cells
were sub-cultured as well. After additional 24 h, si-SCR-
transfected cells and one plate of si-Circ-transfected cells
were harvested; fresh medium supplemented either with
MG132 (10 μM, dissolved in DMSO, Sigma-Aldrich) or
with an equal volume of 100% DMSO (Sigma-Aldrich) was
added to the other two si-Circ-transfected plates. DMSO-
treated and MG132-treated cells were harvested after 5 h of
treatment. The experiment was performed in at least 3
biological replicates.
Flow cytometric analysis of cell cycle
Cells were pelleted and 100 μl PBS (Sigma-Aldrich) and
10 μl RNase-A (Sigma-Aldrich) were added to the pellet
(1 mg/ml). Cells were incubated at 37 °C for 30 min. Then
propidium iodide (Sigma-Aldrich) was added (1 mg/ml) and
cells were incubated at room temperature, in the dark, for
5 min. Samples were processed using a BD FACSCalibur
Flow Cytometer (BD Biosciences, Franklin Lakes, NJ,
USA) machine and Cell Quest Pro (BD Biosciences) soft-
ware. Results were analyzed using ModFit 3.1 software
(BD Biosciences). Biological replicates performed
for each experiment were at least: 2 (Fig. 1b), 3 (Fig. 3a, b),
2 (Figure S2C).
RNA isolation, treatments, and analysis
Total RNA was extracted with Qiazol reagent (Qiagen,
Hilden, Germany) and Direct-zol RNA Miniprep kit (Zymo
Research, Irvine, CA, USA), according to the manu-
facturer’s protocol. Reverse transcription reaction was per-
formed using PrimeScript RT Reagent Kit (Takara Bio
USA) on an appropriate amount of RNA (usually between
100 and 500 ng). cDNA was diluted to 0.7–1 ng/μl with
bidistilled water and used for the qRT-PCR reaction. qRT-
PCR was performed as follows: 6 μl cDNA (0.7–1 ng/μl)
were added to 7.5 μl PowerUp SYBR Green Master Mix
(Thermo Fisher Scientific) and 1.5 μl of a 5 μM primers
mix. DNA amplification was achieved following the man-
ufacturer’s protocol. An ABI 7500 Fast qPCR (Thermo
Fisher Scientific) instrument was used for amplification and
data analysis. RNA levels are relative to HPRT mRNA (in
experiments performed in human primary myoblasts),
GAPDH mRNA (in experiments performed in RD and RH4
cells), ACTB mRNA (in proteasome inhibition experi-
ments). Oligonucleotide sequences are provided in Table
S4. Primers for circ-ZNF609 and ZNF609 mRNA were
described in [10]. Primers for IFN-A1/13, IFN-A10, IFN-
A21 were described in the reference [52]. Biological
replicates performed for each experiment were at least:
3 (Fig. 1d–f), 3 (Fig. 2a, c), 3 (Fig. 3c, d), 3 (Figure S3C).
Regarding qRT-PCR plots, data are shown as means ±
standard error of technical replicates (error bars).
Western Blot
Cells were harvested with a suitable volume of Protein
Extraction Buffer (100 mM Tris pH 7.5, EDTA 1mM, SDS
2%, PIC 1× (Complete-EDTA free, Roche—Merck,
Darmstadt, Germania), incubated 20 min on ice and cen-
trifuged at 15,000×g for 15 min at 4 °C. Proteins (25–30 μg)
were loaded on 4–12% bis-tris-acrylamide gel (Thermo
F. Rossi et al.
Fisher Scientific-Life Technologies) and transferred to a
nitrocellulose membrane. The membrane was blocked in
5% milk and hybridized with the following antibodies: anti-
Gapdh (6C5, #sc-32233, Santa Cruz Biotechnology, Dallas,
TX, USA), anti-Rb (G3-245, #554136, BD Biosciences),
anti-phospho-Rb Ser780 (D59B7, #8180, Cell Signaling
Technology, Danvers, MA, USA), anti-Akt (#9272, Cell
Signaling Technology), anti-phospho-Akt Ser473 (#9271,
Cell Signaling Technology), anti-p27Kip1 (C-19, sc-528,
Santa Cruz Biotechnology), anti-Actin (#A3854, Sigma-
Aldrich), anti-Akt3 (ab152157, Abcam, Cambridge, UK).
Images were acquired using a ChemiDoc MP Imager (Bio-
Rad, Hercules, CA, USA) and analyzed using Image Lab
5.2.1 software (Bio-Rad). Whole images were adjusted in
contrast and brightness when necessary. Protein samples
were run twice, to allow multiple hybridizations for proteins
with the same molecular weight. Gapdh hybridization was
performed for each running, but only one Gapdh hybridi-
zation is shown. However, for protein quantification each
specific signal was compared with the corresponding Gapdh
hybridization. Biological replicates performed for each
experiment were at least: 3 (Fig. 3e and S2D), 3 (Fig. 3f and
S2E), 2 (Fig. S3F).
Data availability
RNA sequencing raw data have been deposited at Gene
Expression Omnibus (GSE117609).
Acknowledgements The authors acknowledge O. Sthandier and
M. Marchioni for technical help, S. Camero and M. Guarnacci for
experimental support, M. Caruso for anti-Rb and anti-phospho-Rb
antibodies, B. Pizer and R. Shukla for biological samples. The Tele-
thon Network Genetic Biobanks (GTB12001F) and EuroBioBank are
acknowledged for biological samples. This work was partially sup-
ported by grants from: ERC-2013 (AdG 340172–MUNCODD),
Telethon (GGP16213), Human Frontiers Science Program Award
RGP0009/2014, Parent Project Italia, AFM-Telethon (17835), Epigen-
Epigenomics Flagship Project and EU—H2020 Marie Sklodowska-
Curie Action (721890, circRTrain).
Compliance with ethical standards
Conflict of interest The authors F.R., I.L., F.M., G.Di T., C.D., and
I.B. have a pending application in Italy for a patent entitled “Diagnosis
and treatment of tumor”. The remaining authors declare that they have
no conflict of interest.
Publisher’s note: Springer Nature remains neutral with regard to
jurisdictional claims in published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as
long as you give appropriate credit to the original author(s) and the
source, provide a link to the Creative Commons license, and indicate if
changes were made. The images or other third party material in this
article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not
included in the article’s Creative Commons license and your intended
use is not permitted by statutory regulation or exceeds the permitted
use, you will need to obtain permission directly from the copyright
holder. To view a copy of this license, visit http://creativecommons.
org/licenses/by/4.0/.
References
1. Salzman J, Gawad C, Wang PL, Lacayo N, Brown PO. Circular
RNAs are the predominant transcript isoform from hundreds of
human genes in diverse cell types. Preiss T, editor. PLoS ONE.
2012;7:e30733.
2. Memczak S, et al. Circular RNAs are a large class of animal
RNAs with regulatory potency. Nature. 2013;495:333–8.
3. Jeck WR, et al. Circular RNAs are abundant, conserved, and
associated with ALU repeats. RNA. 2013;19:141–57.
4. Piwecka M, et al. Loss of a mammalian circular RNA locus causes
miRNA deregulation and affects brain function. Science.
2017;357:eaam8526.
5. Zheng Q, et al. Circular RNA profiling reveals an abundant cir-
cHIPK3 that regulates cell growth by sponging multiple miRNAs.
Nat Commun. 2016;7:11215.
6. Tang CM, et al. CircRNA-000203 enhances the expression of
fibrosis-associated genes by derepressing targets of miR-26b-5p,
Col1a2 and CTGF, in cardiac fibroblasts. Sci Rep. 2017;7:40342.
7. Hansen TB, et al. Natural RNA circles function as efficient
microRNA sponges. Nature. 2013;495:384–8.
8. Du WW, Yang W, Liu E, Yang Z, Dhaliwal P, Yang BB. Foxo3
circular RNA retards cell cycle progression via forming ternary
complexes with p21 and CDK2. Nucleic Acids Res.
2016;44:2846–58.
9. Abdelmohsen K, et al. Identification of HuR target circular RNAs
uncovers suppression of PABPN1 translation by CircPABPN1.
RNA Biol. 2017;14:361–9.
10. Legnini I, et al. Circ-ZNF609 is a circular RNA that can be
translated and functions in myogenesis. Mol Cell. 2017;66:22–37.
e9.
11. Pamudurti NR, et al. Translation of CircRNAs. Mol Cell.
2017;66:9–21.e7.
12. Zhang M, et al. A novel protein encoded by the circular form of
the SHPRH gene suppresses glioma tumorigenesis. Oncogene.
2018;37:1805–14.
13. Ahmed I, et al. Altered expression pattern of circular RNAs in
primary and metastatic sites of epithelial ovarian carcinoma.
Oncotarget. 2016;7:36366–81.
14. Bonizzato A, Gaffo E, Te Kronnie G, Bortoluzzi S. CircRNAs in
hematopoiesis and hematological malignancies. Blood Cancer J.
2016;6:e483.
15. Xia W, et al. Circular RNA has_circ_0067934 is upregulated in
esophageal squamous cell carcinoma and promoted proliferation.
Sci Rep. 2016;6:35576.
16. Patop IL, Kadener S. circRNAs in cancer. Curr Opin Genet Dev.
2018;48:121–7.
17. Guarnerio J, et al. Oncogenic role of fusion-circRNAs derived
from cancer-associated chromosomal translocations. Cell.
2016;165:289–302.
18. Egas-Bejar D, Huh WW. Rhabdomyosarcoma in adolescent and
young adult patients: current perspectives. Adolesc Health Med
Ther. 2014;5:115–25.
19. Sun X, Guo W, Shen JK, Mankin HJ, Hornicek FJ, Duan Z.
Rhabdomyosarcoma: advances in molecular and cellular biology.
Sarcoma. 2015;2015:1–14.
Circ-ZNF609 regulates G1-S progression in rhabdomyosarcoma
20. Schaaf GJ, et al. Full transcriptome analysis of rhabdomyo-
sarcoma, normal, and fetal skeletal muscle: statistical comparison
of multiple SAGE libraries. FASEB J. 2005;19:404–6.
21. J. Hertzog P, Hwang S.Y, Kola I. Role of interferons in the reg-
ulation of cell proliferation, differentiation, and development. Mol
Reprod Dev. 1994;39:226–32.
22. Clemens MJ, McNurlan MA. Regulation of cell proliferation and
differentiation by interferons. Biochem J. 1985;226:345–60.
23. Platanias LC. Mechanisms of type-I- and type-II-interferon-
mediated signalling. Nat Rev Immunol. 2005;5:375–86.
24. Sangfelt O, Erickson S, Grandér D. Mechanisms of Interferon-
induced cell cycle arrest. Front Biosci. 2000;5:d479–487.
25. DeGregori J, Kowalik T, Nevins JR. Cellular targets for activation
by the E2F1 transcription factor include DNA synthesis- and G1/
S-regulatory genes. Mol Cell Biol. 1995;15:4215–24.
26. Iwanaga R, et al. Identification of novel E2F1 target genes regu-
lated in cell cycle-dependent and independent manners. Onco-
gene. 2006;25:1786–98.
27. Chen T, et al. The retinoblastoma protein selectively represses
E2F1 targets via a TAAC DNA element during cellular senes-
cence. J Biol Chem. 2012;287:37540–51.
28. Mori K, et al. Linkage of E2F1 transcriptional network and cell
proliferation with respiratory chain activity in breast cancer cells.
Cancer Sci. 2016;107:963–71.
29. Laplante M, Sabatini DM. mTOR signaling in growth control and
disease. Cell. 2012;149:274–93.
30. Besson A, Gurian-west M, Chen X, Kelly-spratt KS, Kemp CJ,
Roberts JM. A pathway in quiescent cells that controls p27
Kip1 stability, subcellular localization, and tumor suppression.
Genes Dev. 2006;20:47–64.
31. Geistlinger L, Csaba G, Küffner R, Mulder N, Zimmer R. From
sets to graphs: towards a realistic enrichment analysis of tran-
scriptomic systems. Bioinformatics. 2011;27:366–73.
32. Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M.
KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids
Res. 1999;27:29–34.
33. Alvarez MJ, et al. Network-based inference of protein activity
helps functionalize the genetic landscape of cancer. Nat Genet.
2016;48:838–47.
34. Krautkramer KA, et al. Tcf19 is a novel islet factor necessary for
proliferation and survival in the INS-1 β-cell line. Am J Physiol
Endocrinol Metab. 2013;305:E600–10.
35. Ying H, Xu Z, Chen M, Zhou S, Liang X, Cai X. Overexpression
of Zwint predicts poor prognosis and promotes the proliferation of
hepatocellular carcinoma by regulating cell-cycle-related proteins.
Onco Targets Ther. 2018;ume 11:689–702.
36. Endo H, Ikeda K, Urano T, Horie-Inoue K, Inoue S. Terf/
TRIM17 stimulates degradation of kinetochore protein ZWINT
and regulates cell proliferation. J Biochem. 2012;151:139–44.
37. Feng G, et al. MLF1IP promotes normal erythroid proliferation
and is involved in the pathogenesis of polycythemia vera. FEBS
Lett. 2017;591:760–73.
38. Wang S, et al. Centromere protein U is a potential target for gene
therapy of human bladder cancer. Oncol Rep. 2017;38:735–44.
39. Liu P, Slater DM, Lenburg M, Nevis K, Cook JG, Vaziri C.
Replication licensing promotes cyclin D1 expression and G1
progression in untransformed human cells. Cell Cycle.
2009;8:125–36.
40. Qu K, et al. MCM7 promotes cancer progression through cyclin
D1-dependent signaling and serves as a prognostic marker for
patients with hepatocellular carcinoma. Cell Death Dis. 2017;8:
e2603–e2603.
41. Mio C, et al. MCM5 as a target of BET inhibitors in thyroid
cancer cells. Endocr Relat Cancer. 2016;23:335–47.
42. Narita M, et al. Rb-mediated heterochromatin formation and
silencing of E2F target genes during cellular senescence. Cell.
2003;113:703–16.
43. Galea GL, et al. Old age and the associated impairment of bones’
adaptation to loading are associated with transcriptomic changes
in cellular metabolism, cell-matrix interactions and the cell cycle.
Gene. 2017;599:36–52.
44. Bracken AP, Ciro M, Cocito A, Helin K. E2F target genes:
unraveling the biology. Trends Biochem Sci. 2004;29:409–17.
45. Fabregat A, et al. The reactome pathway knowledgebase. Nucleic
Acids Res. 2018;46(D1):D649–D655. https://doi.org/10.3180/R-
HSA-6804116.2
46. Felix CA, et al. Frequency and diversity of p53 mutations in
childhood rhabdomyosarcoma. Cancer Res. 1992;6:2243–7.
47. Miyachi M, et al. Restoration of p53 pathway by nutlin-3 induces
cell cycle arrest and apoptosis in human rhabdomyosarcoma cells.
Clin Cancer Res. 2009;15:4077–85.
48. Taylor AC, et al. P53 mutation and MDM2 amplification fre-
quency in pediatric rhabdomyosarcoma tumors and cell lines. Med
Pediatr Oncol. 2000;35:96–103.
49. Peng L, et al. Circular RNA ZNF609 functions as a competitive
endogenous RNA to regulate AKT3 expression by sponging miR-
150-5p in Hirschsprung’s disease. Oncotarget. 2017;8:808–18.
50. Hinson ARP, Jones R, Crose LES, Belyea BC, Barr FG, Linardic
CM. Human rhabdomyosarcoma cell lines for rhabdomyosarcoma
research: utility and pitfalls. Front Oncol. 2013;3(July):1–12.
51. Megiorni F, Camero S, Ceccarelli S, Mcdowell HP, Mannarino O,
Marampon F, et al. DNMT3B in vitro knocking-down is able to
reverse embryonal rhabdomyosarcoma cell phenotype through
inhibition of proliferation and induction of myogenic differentia-
tion. Oncotarget. 2016;7:79342–56.
52. Remoli ME, et al. Selective expression of type I IFN genes in
human dendritic cells infected with Mycobacterium tuberculosis. J
Immunol. 2002;169:366–74.
F. Rossi et al.
